tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeet Mukherjee, 68 are a BUY (100%).
Analyst Jeet Mukherjee, currently employed at BTIG, carries an average stock price target met ratio of 18.67% that have a potential upside of 28.66% achieved within 71 days.
Jeet Mukherjee’s has documented 134 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCAX, Bicara Therapeutics.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 9/9/2025. The price target of $87 was fulfilled within 23 days with a profit of $42.07 (93.63%) receiving and performance score of 40.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2026
$21
$14.59 (227.61%)
$24
3 months 2 days ago
(10-Aug-2026)
8/22 (36.36%)
$12.01 (133.59%)
106
Buy Since 25-Feb-2026
$14
$7.59 (118.41%)
$19
3 months 2 days ago
(10-Aug-2026)
0/2 (0%)
$5.01 (55.73%)
Hold Since 18-Sep-2025
$12
$5.59 (87.21%)
$11
3 months 7 days ago
(05-Aug-2026)
12/19 (63.16%)
$3.6 (42.86%)
129
Buy Since 09-May-2024
$11
$4.59 (71.61%)
$15
3 months 7 days ago
(05-Aug-2026)
1/8 (12.5%)
$2.6 (30.95%)
400
Buy Since 12-Mar-2025
$18
$11.59 (180.81%)
$18
3 months 8 days ago
(04-Aug-2026)
0/7 (0%)
$9 (100.00%)
Which stock is Jeet Mukherjee most bullish on?
Which stock is Jeet Mukherjee most reserved on?
What Year was the first public recommendation made by Jeet Mukherjee?
